Inter‐rater and intrarater agreement and reliability in clinical staging of hidradenitis suppurativa/acne inversaChristos C. Zouboulis, Viktor A. Zouboulis, V. Dente et al.|British Journal of Dermatology|2019Cited by 16
Towards the development of upgrade criteria for the treatment of hidradenitis suppurativa with biologicsGeorgios Nikolakis, Christos C. Zouboulis, Erkan Alpsoy et al.|Journal of the European Academy of Dermatology and Venereology|2025Cited by 6
Delphi consensus: First‐line use of biologics and small molecules in hidradenitis suppurativaGeorgios Nikolakis, Hessel H. Van Der Zee, Florian Anzengruber et al.|Journal of the European Academy of Dermatology and Venereology|2026Cited by 2
Infectious Disease Screening prior to Systemic Immunomodulatory Therapy in Hidradenitis Suppurativa: Consensus Guidelines from the Asia-Pacific Hidradenitis Suppurativa FoundationEmily Kozera, John W. Frew, Martina L. Porter et al.|Dermatology|2023Cited by 1
Supplementary Material for: Infectious Disease Screening Prior to Systemic Immunomodulatory Therapy in Hidradenitis Suppurativa: Consensus Guidelines from the Asia-Pacific Hidradenitis Suppurativa FoundationKozera E.K., Frew J.W., Martina L. Porter et al.|Figshare|2023Cited by 0